Neuroprotective Mechanism of : Upregulation of Hippocampal Insulin-degrading Enzyme Protein Expression and Acceleration of Amyloid-beta Degradation

Overview

Journal Neural Regen Res

Date 2017 May 30

PMID 28553348

Citations 14

Authors

Na Wang

Yong-ming Jia

Bo Zhang

Di Xue

Maharjan Reeju

Yan Li

Shu-Ming Huang

Xue-Wei Liu

Affiliations

Soon will be listed here.

Abstract

is a Chinese herbal formula composed of , , and . It has been used in China for many years for treating amnesia. ameliorates amyloid-β (Aβ)-induced cognitive dysfunction and is neuroprotective , but its precise mechanism remains unclear. Expression of insulin-degrading enzyme (IDE), which degrades Aβ, is strongly correlated with cognitive function. Here, we injected rats with exogenous Aβ (200 μM, 5 μL) into the hippocampus and subsequently administered (0.54 or 1.08 g/kg/d) intragastrically for 21 consecutive days. Hematoxylin-eosin and Nissl staining revealed that protected neurons against Aβ-induced damage. Furthermore, enzyme-linked immunosorbent assay, western blot and polymerase chain reaction results showed that decreased Aβ protein levels and increased expression of IDE protein, but not mRNA, in the hippocampus. Our findings reveal that facilitates hippocampal Aβ degradation and increases IDE expression, which leads, at least in part, to the alleviation of hippocampal neuron injury in rats.

Citing Articles

Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases.

Chauhan P, Wadhwa K, Mishra R, Gupta S, Ahmad F, Kamal M Mol Neurobiol. 2024; 61(12):10747-10769.

PMID: 38780722 DOI: 10.1007/s12035-024-04222-4.

Network pharmacology implicates traditional Chinese medicine in regulating systemic homeostasis to benefit Alzheimer's disease.

Tsai S, Huang H Tzu Chi Med J. 2023; 35(2):120-130.

PMID: 37261294 PMC: 10227678. DOI: 10.4103/tcmj.tcmj_125_22.

Therapeutic Potential of Active Components from and in Neurological Disorders and Their Application in Korean Medicine.

Kim C, Kwak T, Bae M, Shin H, Choi B J Pharmacopuncture. 2023; 25(4):326-343.

PMID: 36628348 PMC: 9806153. DOI: 10.3831/KPI.2022.25.4.326.

Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.

Wang K, Yang R, Chen T, Qin M, Wang P, Kong M Chin J Integr Med. 2022; 29(5):413-423.

PMID: 36474082 DOI: 10.1007/s11655-022-3589-5.

Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment.

Deng C, Chen H, Meng Z, Meng S Front Endocrinol (Lausanne). 2022; 13:955618.

PMID: 36213283 PMC: 9533021. DOI: 10.3389/fendo.2022.955618.

References

Perez A, Morelli L, Cresto J, Castano E . Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem Res. 2000; 25(2):247-55. DOI: 10.1023/a:1007527721160. View

Cheng H, Wang L, Shi T, Shang Y, Jiang L . Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis. Int J Neurosci. 2014; 125(5):328-35. DOI: 10.3109/00207454.2014.941440. View

Asle-Rousta M, Kolahdooz Z, Oryan S, Ahmadiani A, Dargahi L . FTY720 (fingolimod) attenuates beta-amyloid peptide (Aβ42)-induced impairment of spatial learning and memory in rats. J Mol Neurosci. 2013; 50(3):524-32. DOI: 10.1007/s12031-013-9979-6. View

Awasthi M, Singh S, Pandey V, Dwivedi U . Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products. J Neurol Sci. 2016; 361:256-71. DOI: 10.1016/j.jns.2016.01.008. View

Quan Q, Wang J, Li X, Wang Y . Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease. PLoS One. 2013; 8(3):e59155. PMC: 3592813. DOI: 10.1371/journal.pone.0059155. View

Vekrellis K, Ye Z, Qiu W, Walsh D, Hartley D, Chesneau V . Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci. 2000; 20(5):1657-65. PMC: 6772918. View

Leissring M . Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease. CNS Drugs. 2016; 30(8):667-75. PMC: 10148599. DOI: 10.1007/s40263-016-0364-1. View

Chai G, Wang Y, Yasheng A, Zhao P . Beta 2-adrenergic receptor activation enhances neurogenesis in Alzheimer's disease mice. Neural Regen Res. 2016; 11(10):1617-1624. PMC: 5116841. DOI: 10.4103/1673-5374.193241. View

Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M . Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999; 65(3):664-70. PMC: 1377972. DOI: 10.1086/302553. View

10.

Jang S, Yu J, Kim S, Kim G, Park D, Lee D . An Aβ42 uptake and degradation via Rg3 requires an activation of caveolin, clathrin and Aβ-degrading enzymes in microglia. Eur J Pharmacol. 2015; 758:1-10. DOI: 10.1016/j.ejphar.2015.03.071. View

11.

Qiu W, Walsh D, Ye Z, Vekrellis K, Zhang J, Podlisny M . Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem. 1998; 273(49):32730-8. DOI: 10.1074/jbc.273.49.32730. View

12.

Hu Y, Liu M, Liu P, Yan J, Liu M, Zhang G . Effect of kai xin san on learning and memory in a rat model of paradoxical sleep deprivation. J Med Food. 2013; 16(4):280-7. DOI: 10.1089/jmf.2012.2486. View

13.

Zhang S, Wang X, Zhang Y, Di Q, Shi J, Qian M . Indirubin-3'-monoxime suppresses amyloid-beta-induced apoptosis by inhibiting tau hyperphosphorylation. Neural Regen Res. 2016; 11(6):988-93. PMC: 4962599. DOI: 10.4103/1673-5374.184500. View

14.

Li L, Luo J, Chen D, Tong J, Zeng L, Cao Y . BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease. Neural Regen Res. 2016; 11(3):447-53. PMC: 4829010. DOI: 10.4103/1673-5374.179057. View

15.

Ooigawa H, Nawashiro H, Fukui S, Otani N, Osumi A, Toyooka T . The fate of Nissl-stained dark neurons following traumatic brain injury in rats: difference between neocortex and hippocampus regarding survival rate. Acta Neuropathol. 2006; 112(4):471-81. DOI: 10.1007/s00401-006-0108-2. View

16.

Saido T . Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease. Proc Jpn Acad Ser B Phys Biol Sci. 2013; 89(7):321-39. PMC: 3758963. DOI: 10.2183/pjab.89.321. View

17.

Zhang Y, Wang B, Wan H, Zhou Q, Li T . Meta-analysis of the insulin degrading enzyme polymorphisms and susceptibility to Alzheimer's disease. Neurosci Lett. 2013; 541:132-7. DOI: 10.1016/j.neulet.2013.01.051. View

18.

Gu W, Liu D, Zhang M, Zhang H . [Effect of ginsenoside Rb1 on insulin signal transduction pathway in hippocampal neurons of high-glucose-fed rats]. Zhongguo Zhong Yao Za Zhi. 2014; 39(6):1064-8. View

19.

Rodnina M . The ribosome in action: Tuning of translational efficiency and protein folding. Protein Sci. 2016; 25(8):1390-406. PMC: 4972197. DOI: 10.1002/pro.2950. View

20.

Shen Y, Joachimiak A, Rosner M, Tang W . Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature. 2006; 443(7113):870-4. PMC: 3366509. DOI: 10.1038/nature05143. View